Tetanus Immunoglobulin Administration Guidelines

Introduction to TIG Administration

• The Centers for Disease Control and Prevention recommends that tetanus immunoglobulin (TIG) should be administered as soon as possible once the need is identified, with no established time limit that renders it ineffective for wound prophylaxis 1, 2, 3, 4, 5.

Standard Prophylactic Dosing

• The standard prophylactic dose of TIG is 250 units IM, which should be administered at a separate anatomic site from tetanus toxoid using separate syringes 1, 2, 3, 4, 5.

Indications for TIG in Wound Management

• TIG is indicated for wounds other than clean, minor wounds in patients who have unknown or uncertain tetanus vaccination status, or have received fewer than three previous tetanus toxoid doses 1, 2, 3, 4, 5.

Important Clinical Considerations

• TIG provides immediate passive immunity by supplying preformed antibodies, making its administration time-sensitive but not restricted to the first 24-48 hours 1, 2, 3, 4, 5.
• Patients treated with rituximab in the past 6 months may have reduced responses to tetanus toxoid vaccination and should receive TIG for contaminated wounds 7.

Common Pitfalls to Avoid

• TIG should not be withheld simply because 3 days have elapsed since injury, as the guidelines emphasize giving it "as soon as possible" but do not establish an absolute cutoff 1, 2, 3, 4, 5.